ANTICIPATED IMPACT OF LIVE BIOTHERAPEUTIC PRODUCTS ON FECAL MICROBIOTA TRANSPLANTATION (FMT) PRACTICE

被引:0
|
作者
Scharfen, James
Kim, Alison M.
Fredell, Lydia
Nersesova, Yanina
Serra, Sonya M.
Lewis, James D.
Wu, Gary D.
Laine, Loren
Kelly, Colleen R.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su1603
引用
收藏
页码:S650 / S650
页数:1
相关论文
共 50 条
  • [41] Patient perception and approval of fecal microbiota transplantation (FMT) as an alternative treatment option for ulcerative colitis
    Roggenbrod, Sebastian
    Schuler, Constantin
    Haller, Bernhard
    Sohn, Maximilian
    Storr, Martin
    Schepp, Wolfgang
    Gundling, Felix
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (03): : 296 - 303
  • [42] Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT)
    Nobili, Valerio
    Mosca, Antonella
    Alterio, Tommaso
    Cardile, Sabrina
    Putignani, Lorenza
    PROBIOTICS AND CHILD GASTROINTESTINAL HEALTH: ADVANCES IN MICROBIOLOGY, INFECTIOUS DISEASES AND PUBLIC HEALTH, VOL 10, 2019, 1125 : 85 - 100
  • [43] Safety of Fecal Microbiota Transplantation (FMT) in Immunocompromised (Ic) Patients with Inflammatory Bowel Disease (IBD)
    Brandt, Lawrence
    Aroniadis, Olga
    Greenberg, Adam
    Borody, Thomas
    Finlayson, Sarah
    Furnari, Vanessa
    Kelly, Colleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S556 - S556
  • [44] Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children
    Fareed, Shaaz
    Sarode, Neha
    Stewart, Frank J.
    Malik, Aneeq
    Laghaie, Elham
    Khizer, Saadia
    Yan, Fengxia
    Pratte, Zoe
    Lewis, Jeffery
    Immergluck, Lilly Cheng
    PEERJ, 2018, 6
  • [45] Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome
    El-Salhy, Magdy
    Kristoffersen, Anja Brathen
    Valeur, Jorgen
    Casen, Christina
    Hatlebakk, Jan Gunnar
    Gilja, Odd Helge
    Hausken, Trygve
    NEUROGASTROENTEROLOGY AND MOTILITY, 2022, 34 (01):
  • [46] The Role of Loperamide in Conjunction With Fecal Microbiota Transplantation (FMT) for Recurrent Clostridioides difficile Infection (rCDI)
    Nayi, Vipul
    Brandt, Lawrence
    Aroniadis, Olga
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S97 - S98
  • [47] Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes
    Rohit Anand
    Yang Song
    Shashank Garg
    Mohit Girotra
    Amitasha Sinha
    Anita Sivaraman
    Laila Phillips
    Sudhir K. Dutta
    Digestive Diseases and Sciences, 2017, 62 : 1002 - 1008
  • [48] Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea
    Gweon, Tae-Geun
    Lee, Yoo Jin
    Kim, Kyeong Ok
    Yim, Sung Kyun
    Soh, Jae Seung
    Kim, Seung Young
    Park, Jae Jun
    Shin, Seung Yong
    Lee, Tae Hee
    Choi, Chang Hwan
    Cho, Young-Seok
    Yong, Dongeun
    Chung, Jin-Won
    Lee, Kwang Jae
    Lee, Oh Young
    Choi, Myung-Gyu
    Choi, Miyoung
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2022, 28 (01) : 28 - 42
  • [49] Treating Clostridioides difficile: Could Microbiota-based Live Biotherapeutic Products Provide the Answer?
    Nagarakanti, Sandhya
    Orenstein, Robert
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 3137 - 3143
  • [50] Microbiota-Based Live Biotherapeutic Products for Clostridioides Difficile Infection- The Devil is in the Details
    Monday, Lea
    Tillotson, Glenn
    Chopra, Teena
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 623 - 639